Overall survival months | Univariate analysis p-value | Multivariate analysis | |||
HR | 95% CI | p-value | |||
Age | |||||
<60 years | 20.1 (15.1–25.0) | 0.113 | |||
>60 years | 14.2 (7.3–21.1) | ||||
Sex | |||||
Female | 22.7 (16.8–28.5) | 0.012 | 1.588 | 0.860–2.93 | 0.139 |
Male | 14.2 (11.9–16.5) | ||||
ECOG | |||||
0–1 | 20.7 (16.3–25.2) | <0.001 | 2.04 | 1.168–3.56 | 0.012 |
2–4 | 10.6 (8.7–12.5) | ||||
Stage | |||||
III | 24.3 (8.5–40.1) | 0.029 | 2.16 | 1.08–4.30 | 0.029 |
IV | 15.0 (9.6–20.4) | ||||
Smoking status | |||||
Positive | 24.3 (19.4–29.2) | 0.046 | 1.204 | 0.661–2.19 | 0.544 |
Negative | 14.4 (12.3–16.5) | ||||
Wood smoke exposure | |||||
Positive | 15.2 (9.7–20.7) | 0.921 | |||
Negative | 20.4 (13.8–27.1) | ||||
EGFR status | |||||
Positive | 27.3 (11.5–43.1) | 0.027 | 1.999 | 1.142–3.498 | 0.015 |
Negative | 14.8 (11.3–18.3) | ||||
Groups | |||||
Intermediate | 16.8 (11.8–21.8) | 0.023 | 0.804 | 0.624–1.036 | 0.037 |
High | 25.0 (15.4–34.6) |
Data are presented as median (95% CI), unless otherwise stated. HR: hazard ratio; ECOG: Eastern Cooperative Oncology Group; EGFR: epidermal growth factor receptor.